Peter HENDRICKS – Birmingham

Biographie 

I am a University Professor and clinical psychologist with a longstanding interest in addiction. I am particularly interested in the development of novel and more efficacious interventions for substance use disorders and comorbid conditions, with an emphasis on vulnerable populations and mechanisms of change.

I also have a longstanding interest in psychedelics, including their use in clinical settings, potential therapeutic applications and risks, epidemiology, and effects on brain functioning. I am currently completing the first randomized controlled trial of psilocybin in the treatment of cocaine use disorder—a trial that includes assessment of resting state functional connectivity—and I serve as site PI of a NIDA-funded study of psilocybin in the treatment of tobacco dependence (U01DA052174-01A1). Furthermore, I am PI of a randomized controlled trial of psilocybin in the treatment of fibromyalgia—a trial that also includes a brain imaging component—and a randomized controlled trial of very low doses or “microdoses” of psilocybin in the treatment of demoralization. I am therefore ideally positioned to successfully complete the proposed project focused on mechanisms of change in psilocybin-assisted treatment for cocaine use disorder.